General Medicine and Primary Care

Episodes 1-16 of 97

Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
NeuroFrontiers
Bridging Inpatient to Outpatient Schizophrenia Care: Solutions for Safer Transitions
- Shelina Ramnarine, PhD
- Michelle Scargle, MD
- Margaret Emerson, DNP, APRN, PMHNP-BC
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
Global Neurology Academy
Negative Symptoms in Schizophrenia: Identifying and Managing the Hidden Burden
- Brian P. McDonough, MD, FAAFP
- Ahmed Makhlouf, MD
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
NeuroFrontiers
Advancing Schizophrenia Care: When and How to Use Novel Therapies in Complex Patients
- Charles Turck, PharmD, BCPS, BCCCP
- Ragy R. Girgis, MD, MS
- Desiree Matthews, PMHNP-BC
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
NeuroFrontiers
Using fMRI to Identify Early Alzheimer’s Disease Subgroups
- Hamid Abuwarda, PhD, BS
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
NeuroFrontiers
Evaluating AR1001: A Phase 3 Trial in Early Alzheimer’s Disease
- Sharon Sha, MD, MS
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
NeuroFrontiers
Understanding Schizophrenia: The Role of Neurotransmission and Inflammation
- Jeffrey A. Lieberman, MD
Harnessing AI to Predict and Prevent Schizophrenia Relapse
Harnessing AI to Predict and Prevent Schizophrenia Relapse
NeuroFrontiers
Harnessing AI to Predict and Prevent Schizophrenia Relapse
- Matcheri S. Keshavan, MD
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
NeuroFrontiers
Engaging Patients and Caregivers in Schizophrenia: A Collaborative Care Approach
- Shelina Ramnarine, PhD
- Apurva Bhatt, MD
- Shannon Pagdon, BA
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
NeuroFrontiers
Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
- Charles Turck, PharmD, BCPS, BCCCP
- David Kimhy, PhD
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
CME/CE
Are All VMAT2s The Same? Data Driven Treatment Decisions for Tardive Dyskinesia
0.25 credits
- Christoph U. Correll, MD
- Jonathan M. Meyer
0.25 credits
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
Global Neurology Academy
Prevention on the Horizon: Early Intervention and Risk Reduction in MS Care
- Vikram V. Bhise, MD
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
Global Neurology Academy
Evolving Diagnostic and Prognostic Strategies in Multiple Sclerosis Care
- Ashley Baker, MSN, PMHNP
- Jay Avasarala, MD, PhD
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
Clinician's Roundtable
Genetic Testing in Pediatrics: Identifying Neurodevelopmental Disorders Early
- Jennifer M. Kalish, MD, PhD, FAAP
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
NeuroFrontiers
Understanding Antibody-Mediated Demyelinating Diseases: Key Differences From MS
- Michael Levy, MD, PhD
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
NeuroFrontiers
Navigating MS Diagnosis in Older Adults: Distinguishing Comorbidities and Mimics
- Le Hua, MD
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab
NeuroFrontiers
Timing Matters: Influenza Vaccination Response in MS Patients on Ofatumumab

1/6

General Medicine and Primary Care

Episodes 1-16 of 97

NEED HELP?

Contact us

NEED HELP?

Contact us

Episodes 1-16 of 97

Title

Share on ReachMD